Kelly Sommers
Physician Assistant · Los Angeles, CANPI 1962289645
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 286 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,934, more than ten times the $134 reported in 2023. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 286 payments — averaging $22.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$735
- Tactile Systems Technology Inc$640
- Abbott$527
- Bard Peripheral Vascular, Inc.$391
- Cvrx, Inc.$364
- E.r. Squibb & Sons, L.L.C.$294
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,437100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 81 | $735 |
| Tactile Systems Technology Inc | 23 | $640 |
| Abbott | 8 | $527 |
| Bard Peripheral Vascular, Inc. | 4 | $391 |
| Cvrx, Inc. | 5 | $364 |
| E.r. Squibb & Sons, L.L.C. | 22 | $294 |
| Merck | 10 | $288 |
| Lilly USA, LLC | 14 | $284 |
| Boehringer Ingelheim | 12 | $277 |
| Lexicon Pharmaceuticals, Inc. | 19 | $244 |
| Medtronic | 2 | $240 |
| Heartflow, Inc. | 7 | $216 |
| Bayer | 9 | $196 |
| Novo Nordisk | 9 | $194 |
| Kiniksa Pharmaceuticals International, PLC | 6 | $194 |
| Alnylam Pharmaceuticals Inc. | 9 | $187 |
| Amgen | 9 | $173 |
| AstraZeneca | 9 | $172 |
| Pfizer | 7 | $149 |
| Angiodynamics, Inc. | 1 | $146 |
| Bridgebio Pharma, Inc. | 2 | $72 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $49 |
| Abiomed | 1 | $49 |
| Philips North America LLC | 1 | $43 |
| Johnson & Johnson | 2 | $43 |
| Esperion Therapeutics, Inc. | 3 | $41 |
| Boston Scientific | 2 | $40 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $37 |
| Biosense Webster, Inc. | 1 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| Koya Medical, Inc. | 1 | $27 |
| Cardiva Medical, Inc. | 1 | $24 |
| Curonix LLC | 1 | $20 |
| Innovation Technologies Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$397
- Barostim Neo System$326
- Flexitouch Plus$279
- Nimbl$279
- RotarexS 6 F x 135 cm$186
- SYMPLICITY G3$159
- Auryon Laser System 100-120 Vac$146
- Lutonix Drug Coated Balloon$132
- Inpefa$122
How this compares
$6,437 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 191 | $259,363 |
| Repatha SureclickEvolocumab | 115 | $90,146 |
| EliquisApixaban | 74 | $72,715 |
| OzempicSemaglutide | 46 | $55,138 |
| TrulicityDulaglutide | 41 | $54,002 |
| XareltoRivaroxaban | 60 | $47,647 |
| EntrestoSacubitril/Valsartan | 34 | $43,471 |
| Praluent PenAlirocumab | 29 | $18,618 |
| VascepaIcosapent Ethyl | 23 | $12,323 |
| SynjardyEmpagliflozin/Metformin Hcl | 12 | $7,667 |
| Repatha SyringeEvolocumab | 11 | $6,074 |
| Amiodarone Hcl | 73 | $2,493 |
| Rosuvastatin Calcium | 186 | $2,437 |
| ClopidogrelClopidogrel Bisulfate | 141 | $1,249 |
| Metoprolol Succinate | 105 | $1,029 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $284 | $313,365232 claims |
| PfizerEliquis | $149 | $72,71574 claims |
| Novo NordiskOzempic | $194 | $55,13846 claims |
| Johnson & JohnsonXarelto | $43 | $47,64760 claims |
| NovartisEntresto | $735 | $43,47134 claims |
| Boehringer IngelheimSynjardy | $277 | $7,66712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Los Angeles
- Asia SullivanLos Angeles$61K
- Felipe FindleyLos Angeles$51K
- Melissa GriffinLos Angeles$39K
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.